Cogdell Spencer Inc.'s CSA core earnings were ahead of Citi driven by lower opex and higher design build income, “but 2011 guidance is below street ests.,” Citi reports.
“A significant goodwill impairment relating to Erdman reduces the carrying value to zero, less than three years after CSA paid $247m for the company,” Citi writes.
“With significant acquisition activity taking place in the healthcare space in recent months, CSA is left waiting for a buyer. The company's ‘Strategic Plan' has been completed and approved, but no details have been provided.”
Cogdell Spencer Inc. closed Thursday at $6.71.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.